Favorable outcome of patients with relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)-Reference-Cited by-同舟云学术

Favorable outcome of patients with relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)

Published:1998-03 Issue:3 Volume:9 Page:289-295
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Josting A.,Kàtay I.,Rueffer U.,Winter S.,Tesch H.,Engert A.,Diehl V.,Wickramanayake P.D.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/9/3/289/19481731/9-3-289.pdf

Reference35 articles.

1. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin’s disease after combination chemotherapy: The low probability of cure;Longo;J Clin Oncol,1992

2. Is there an effective salvage therapy for advanced Hodgkin’s disease?;Cannellos;Ann Oncol,1991

3. The second chance for advanced Hodgkin’s disease;Cannellos;J Clin Oncol,1992

4. Salvage therapy of advanced Hodgkin’s disease: Critical appraisal of curative potential;Buzaid;Am J Med,1987

5. Autologous transplantation for Hodgkin’s disease: Coming of Age?;Biermann;Blood,1994

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-09-06

2. Advances in the treatment of Hodgkin lymphoma: Current and future approaches;Frontiers in Oncology;2023-03-03

3. Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2022-09-19

4. Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease;Frontiers in Pharmacology;2021-06-18

5. Hodgkin lymphoma: A 2020 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2020-06-08